Overall rank by patents
#1,287
Across all tracked assignees
USPTO PatentsView assignee record - 329 granted patents across 31 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
The verdict
Quest holds 329 US patents across 31 technology areas, rank #1,287 of 50,000 tracked assignees.
Quest Diagnostics Investments Llc has been granted 329 US utility patents between 2015 and 2025, placing Quest Diagnostics Investments Llc at rank #1,287 across all assignees tracked by PlainPatent. This portfolio spans 31 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.3 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Quest Diagnostics Investments Llc is one of the more focused assignees in the PatentsView dataset. By volume, Quest sits between Thyssenkrupp Presta Aktiengesellschaft (330 patents, rank #1,283) and Alpha And Omega Semiconductor, Ltd. (327 patents, rank #1,291) - the closest US assignees by grant volume. The composite Innovation Score of 54.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 188 grants, compared with 141 in the 2015–2019 window, a +33% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Quest Diagnostics Investments Llc's 15.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 31 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Quest Diagnostics Investments Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
THYSSENKRUPP PRESTA AKTIENGESELLSCHAFT
330 patents
KunShan Go-Visionox Opto-Electronics Co., Ltd
329 patents
MARY KAY INC
329 patents
Monolithic 3D Inc.
329 patents
SEW-EURODRIVE GMBH & CO. KG
329 patents
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
329 patents
Quest Diagnostics Investments LLC
329 patents
SAFRAN
328 patents
Alpha and Omega Semiconductor, Ltd.
327 patents
What this shows Quest holds 329 patents at rank #1,287, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,287 in granted patent volume.
Other assignees with the most granted patents in Quest's primary technology class.
Quest's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
55 Top 8% higher than 92% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 18 | 5.5% |
| 2016 | 21 | 6.4% |
| 2017 | 30 | 9.1% |
| 2018 | 34 | 10.3% |
| 2019 | 38 | 11.6% |
| 2020 | 38 | 11.6% |
| 2021 | 31 | 9.4% |
| 2022 | 30 | 9.1% |
| 2023 | 28 | 8.5% |
| 2024 | 35 | 10.6% |
| 2025 | 26 | 7.9% |
Top 15 of 31 technology areas
Overall rank by patents
#1,287
Across all tracked assignees
54.7 out of 100
How to use this portfolio
Quest's 329 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.